Trinity Biotech Plc (TRIB)
0.755
+0.05
(+7.70%)
USD |
NASDAQ |
Feb 24, 16:00
0.755
0.00 (0.00%)
After-Hours: 18:13
Trinity Biotech Profit Margin (Quarterly) : -35.88% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amarin Corp. Plc | -15.58% |
| DBV Technologies SA | -- |
| Ascendis Pharma A/S | -13.56% |
| Cellectis SA | 1.67% |
| Akari Therapeutics Plc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -35.95% |
| Return on Invested Capital | -56.11% |
| Gross Profit Margin (Quarterly) | 42.72% |
| Operating Margin (Quarterly) | -3.77% |
| Return on Net Operating Assets | -39.35% |